CT Angiography and Stress Test Show Similar Costs
By MedImaging International staff writers Posted on 08 Jun 2016 |
Image: CT scan of coronary artery centerlines. The PROMISE trial showed CT is as effective as stress tests and SPECT to assess chest pain (Photo courtesy of Duke University).
Computed tomographic angiography (CTA) and functional diagnostic testing strategies for patients with suspected coronary artery disease (CAD) have similar costs, according to a new study.
Researchers at Duke University (Durham, NC, USA), the U.S. National Heart, Lung and Blood Institute (Bethesda, MD, USA), and other institutions conducted a prospective economic study involving 9,649 patients at 190 U.S. centers enrolled in the PROspective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) study between July 2010 and September 2013. Median follow-up was 25 months.
The researchers estimated the technical costs of the initial (outpatient) testing strategy, hospital-based costs and physician fees, discounted at 3% annually and estimated out to three years. The results showed that the mean costs at 90 days were USD 2,494 for the CTA strategy, versus USD 2,240 for the functional strategy, a mean difference of USD 254. The difference was associated with more revascularizations and catheterizations with CTA use. The study was published on May 24, 2016, in Annals of Internal Medicine.
“Despite some fair differences in the prices of these diagnostic tests, there was not a statistical difference between the costs over three years of follow-up,” said lead Daniel Mark, MD, MPH, of Duke. “Coronary CT angiography may not be quite the hoped-for holy grail of cardiology, but its more liberal use following the standards set in PROMISE will not hurt patients, and will not cause a major additional cost burden on the health care system.”
Current guidelines of the American Heart Association (AHA, Dallas, TX, USA) and the American College Cardiology (ACC) call for a stress tests in all patients who show signs of CAD to confirm the diagnosis and define severity of the blockage. CTA is reserved only for patients with borderline stress test results. However, according to the researchers, the much higher accuracy of CTA may be a better first-line test in people with symptoms suggestive of a blocked artery.
Related Links:
Duke University
U.S. National Heart, Lung and Blood Institute
Researchers at Duke University (Durham, NC, USA), the U.S. National Heart, Lung and Blood Institute (Bethesda, MD, USA), and other institutions conducted a prospective economic study involving 9,649 patients at 190 U.S. centers enrolled in the PROspective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) study between July 2010 and September 2013. Median follow-up was 25 months.
The researchers estimated the technical costs of the initial (outpatient) testing strategy, hospital-based costs and physician fees, discounted at 3% annually and estimated out to three years. The results showed that the mean costs at 90 days were USD 2,494 for the CTA strategy, versus USD 2,240 for the functional strategy, a mean difference of USD 254. The difference was associated with more revascularizations and catheterizations with CTA use. The study was published on May 24, 2016, in Annals of Internal Medicine.
“Despite some fair differences in the prices of these diagnostic tests, there was not a statistical difference between the costs over three years of follow-up,” said lead Daniel Mark, MD, MPH, of Duke. “Coronary CT angiography may not be quite the hoped-for holy grail of cardiology, but its more liberal use following the standards set in PROMISE will not hurt patients, and will not cause a major additional cost burden on the health care system.”
Current guidelines of the American Heart Association (AHA, Dallas, TX, USA) and the American College Cardiology (ACC) call for a stress tests in all patients who show signs of CAD to confirm the diagnosis and define severity of the blockage. CTA is reserved only for patients with borderline stress test results. However, according to the researchers, the much higher accuracy of CTA may be a better first-line test in people with symptoms suggestive of a blocked artery.
Related Links:
Duke University
U.S. National Heart, Lung and Blood Institute
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection